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Ever since the publication of the landmark article ‘do practice
guidelines guide practice?’, clinicians and healthcare service
researchers have attempted to address the issue of how best prac-
tice guidelines can guide practice (Lomas et al, 1989). Acceptance
by clinicians of practice guidelines is at its best when guidelines
are designed to improve patient outcome and not to reduce costs or
to improve the indiscriminate endpoint known as ‘quality of care’
which is often considered as cost containment in disguise
(Chassin, 1996). Cancer treatment appears to be favourable for the
development of practice guidelines for at least two reasons; (a)
variations in practice may be disadvantageous for patients (due in
particular to differences in efficacy and side-effects of drugs) and
b) evidence can be found that following recommended strategies
results in improved patient survival, although there is the
difficulty that statistical benefits are difficult to translate at an
individual level. 
DEVELOPMENT OF GUIDELINES 
Cancer treatment guidelines such as those established by the
Standards, Options, Recommendations (SOR) possess some of the
attributes that have been determined to be lead to good obser-
vance: they are evidence-based, worded in a non-ambiguous way
and usually accompanied by decision trees (Grol et al, 1998). The
SORs are written by a group of clinicians where all specialities
concerned by a particular cancer are represented, as well as all
types of institutions (public, teaching, private for-profit and not-
for-profit hospitals, physicians in private practice). This point is
important to ensure that, for example, surgeons will not have to
follow recommendations crafted by radiotherapists. A survey of
French clinicians found a reluctance for specialists to accept
evidence from a group of other specialists. SOR do not require
physicians involved in the treatment of cancer patients to acquire
new skills and, as a rule, do not suggest that responsibility of
management should be shifted from one type of physicians to
another. 
Cancer SORs have taken into account the most sensitive
cultural aspects of the disease. As shown in the comparison
between French and US guidelines on ovarian and breast cancer
prevention, the criteria of medical evidence cannot help in areas of
clinical uncertainties and is replaced by other criteria such as
social preferences or values (Eisinger et al, 1999). Cultural adapta-
tion of SORs is meant to ensure better compliance from physicians
and acceptance by patients in matters where scientific information
has not shown that a given strategy led to a better clinical outcome
than another. It is achieved, via discussions with sociologists,
clinical psychologists and patients’ representatives. 
DISSEMINATION OF GUIDELINES 
This does not mean, however, that guidelines for cancer treatment
will be readily accepted by clinicians. As other authors have
pointed out, acceptance depends not only on physicians’ trust, but
also on at least three other aspects: the magnitude of changes in
practice imposed, and the removal of both administrative ineffi-
ciencies and negative financial incentives (Grol et al, 1998; Ellrodt
et al, 1995). In the case of guidelines for cancer treatment, all three
aspects are to be found to a certain extent depending on the topic.
Cancer SORs require from physicians some changes in their prac-
tice and habits, but it has been shown that implementation of the
standards was possible (Ray-Coquard et al, 1997). 
The SOR patient project will allow the patient to participate in
the implementation of standard procedures by knowing the best
questions to discuss with his physician. Administrative inefficien-
cies may affect the management of cancer patients. One example
is the recommendation of a multidisciplinary approach (Chardot et
al, 1995; Dauplat et al, 1995; Bey et al, 1995; Heron et al, 1995).
This multidisciplinary approach is possible only when all
concerned parties are ready to collaborate and are given the means
and the incentives to do so (Browman et al, 1995; Rodwin, 1993).
The current organization and financing of the French healthcare
system does not particularly promote multidisciplinary manage-
ment of disease (despite repeated statements by the ministry that
cancer treatments must be evidence-based and discussed among
all specialists concerned), except perhaps in cancer centres where
all specialities are to be found. 
The promotion of a multidisciplinary approach requires that
information networks are set up between professionals, with the
funds to match and acknowledgement for physicians in private
practice that discussion with colleagues amounts to a clinic visit
and should be assigned a fee. In academic settings, where payment
may be less of an issue, other non-monetary rewards may be used
as reinforcers. Although we would like to believe that improving
patient outcomes is enough of a reward, some body of evidence
points to the opposite being true (Rodwin, 1993). Thus, it is impor-
tant that participation in guideline development be acknowledged
by academic institutions and appointment committees. 
Negative financial incentives exist through the intricacies of the
current organization of the French healthcare system. Public
hospitals and not-for-profit cancer centres are funded via a capped
yearly budget, which is not adjusted for the number or complexity
of patients. Thus, any increase in the costs of chemotherapy has to
be financed from the hospital’s existing budget. Overspending is
not permitted and results in carried-over debts, which will in turn
lead to investment freeze and personnel reduction. Private for-
profit hospitals have a different, fee-for-service reimbursement,
with a capped fee for chemotherapy and an authorized mark-up
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over the purchase price, which may create an incentive to use
expensive cytostatic drugs. Private hospitals benefit from full
reimbursement for implantable devices, while public hospitals
finance these on the same capped budget as drugs, personnel, etc.
Thus, private for-profit centres have incentives to perform proce-
dures and to use outpatient beds, while public and not-for-profit
hospitals have an incentive to use whatever strategy has the lowest
variable cost. In both the public and the private systems, financing
interferes with the implementation of cancer SORs, although this
is seldom addressed and has not been yet studied in a systematic
way. 
Another obstacle to the dissemination of guidelines is their
number and the amount of paper they represent. The SORs
published to date represent a pile close in height and weight to that
described in the offices of general practitioners (Hibble et al,
1998), but they have the great advantage to be available in CD
form and on the Internet. The computerized SOR with hypertext
links solves the problem of easy access and timely retrieval of
information, provided all physicians concerned are ready to use
this medium. The advent of the Internet, while enabling some physi-
cians to make better informed choices may also increase the gap
between those who are familiar with this technology and those
who are not. This may have several consequences, one of which is
to shift informed patients from non-Internet doctors to Internet
doctors, leaving together the most fragile populations of both
doctors and patients. 
SPONSORSHIP AND CONFLICT OF INTERESTS 
The SOR project is written by group of specialists coming mainly
from the 20 French Cancer Centres, but also from university
hospitals, general hospitals and private practice hospitals. All
specialists are paid by their own employer and did not receive any
salary (the average time for one guideline if a doctor participates
in the writing group is 40 hours). Methodologists are systemati-
cally assigned to each group and at each stage of the process.
Methodologists are full-time on the SOR project and they are paid
by the Cancer Centres with government money. Elaboration of the
various drafts are totally independent from industrial and pharma-
ceutical companies. However, the final draft dissemination is
allowed to benefit from pharmaceutical companies’ grants, but
only for editing books or Internet materials. At this stage, pharma-
ceutical companies may not change anything from the approved
text, which requires reviewing by a large panel of potential users
before final approval by the group of experts and the FNCLCC. 
RELATIONSHIPS WITH GOVERNMENT
AGENCIES 
In France, ANDEM (National Agency for Medical Evaluation)
had became ANAES (National Agency for Accreditation and
Evaluation in the Healthcare System). ANDEM was an active
participant in the SOR project initial phase, with specific help in
methodology of guidelines and in various implementation
techniques. However, the SOR project is independent from
ANAES. The ANAES policy is moving more and more from
guideline development to subcontract guidelines development
leaving medical associations such as FNCLCC with control over
the methodology. 
The SOR programme is part of an international collaboration of
researchers and policy makers who seek to improve the quality
and effectiveness of clinical practice guidelines by establishing a
shared framework for their development, reporting and assess-
ment. The AGREE collaboration (Appraisal of Guidelines,
Research and Evaluation) is an integrated research programme of
the European Union and has the participation of a group of
European countries: Denmark, Finland, France, Germany, Italy,
the Netherlands, Spain, Switzerland and the United Kingdom, as
well as Canada, New Zealand and the USA. 
The authors are indebted to Martine Guesnier and to François
Lemaire MD, for their insights into clinician’s approach to quality
assurance. 
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